NOV Inc (NOV) Misses Q3 EPS by 2c; offers outlook

NOV Inc (NYSE: NOV) reported Q3 EPS of $0.33, $0.02 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $2.19 billion versus the consensus estimate of $2.22 billion.

OUTLOOK

For the fourth quarter of 2024 management expects year-over-year consolidated revenues to be down three to five percent with Adjusted EBITDA between $280 million and $300 million. Full-year Adjusted EBITDA is expected to be near the lower end of the company\'s prior guidance range of between $1.10 billion and $1.18 billion.

For earnings history and earnings-related data on NOV Inc (NOV) click here.

You May Also Be Interested In

• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04
• Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18